School of Medicine

Timothy Miller and Anjan Thakor are the recipients of WashU’s 2026 faculty achievement awards. They were among several people recognized during WashU’s annual Founders Day celebration.

WashU Medicine researchers have rewritten the story on a group of viruses once thought to directly infect human tissue and play a role in gastrointestinal disease. They found that the common virus actually infects gut bacteria, redefining how these viruses impact human health.

Funds from the American Cancer Society will support research by WashU Medicine’s Jennifer Silva-Fisher on drivers of growth and treatment resistance in multiple myeloma.

WashU Medicine maternal-fetal specialists are collaborating with rural obstetricians to reduce patients’ travel time and improve access to high-risk pregnancy care.

Learn how Bob Henkel, the program manager for signage in Enterprise Physical Operations, helps turn the sprawling Medical Campus into a place anyone can navigate.

Eduardo Rosa-Molinar, a professor of cell biology and physiology and of neuroscience at WashU Medicine, was recognized by the American Society for Cell Biology and the Histochemical Society for exceptional research and mentorship in imaging science.

At the Washington University in St. Louis Board of Trustees meeting Sept. 25, several faculty members in Arts & Sciences and at WashU Medicine were promoted or granted tenure, effective that day.

Stephen Stone, MD, an assistant professor of pediatrics at WashU Medicine, was awarded a $3.7 million grant from the National Institutes of Health (NIH) to study a genetic condition that causes the body to lose fat in different regions of the body. The disease causes severe insulin resistance, diabetes and high cholesterol.

WashU Medicine researchers have shown in mice that slowed brain growth in Angelman’s syndrome, a genetic disorder, is caused by elevated levels of a specific molecule that trigger the brain’s stress response.

A collaboration led by WashU Medicine infectious diseases researcher Megan Baldridge, MD, PhD, could lead to new options for vulnerable patients to maintain healthy blood counts.